Cognitive Changes With Gabapentin Treatment
TerminatedNCT04106011
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a single-cohort, prospective, observational study evaluating the effects of gabapentin on cognition. The goal of the study is to determine whether there is a measurable change in cognitive function from baseline in patients who are prescribed gabapentin for the treatment of neuropathic pain.
Study details
- Official title
- Cognitive Changes Associated With Initiation of Gabapentin Treatment in Adults With Chronic Pain
- Conditions
- Neuralgia Peripheral
- Pain
- Interventions
- Drug: Gabapentin
- Diagnostic test: BTACT
- Diagnostic test: BPI
- Diagnostic test: HADS
- Diagnostic test: SLP9
- Diagnostic test: NPSI
- Sponsor
- Washington University School of Medicine
- Start date
- 2020-01-10
- Primary completion
- 2021-02-18
- Sex
- All
- Age range
- from 18 Years to 85 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age between 18 and 85 2. Diagnosis of neuropathic pain 3. Patient report of average daily pain intensity in the last week \>3 on 0-10 Numerical Rating Scale (NRS). 4. Able and willing to sign an IRB-approved written informed consent Exclusion Criteria: 1. Current pregabalin treatment 2. Patient has started taking a new pain medication, or has changed their pain medication dose, in the past 4 weeks. 3. Treatment with opioids exceeding 60mg MME. 4. Severe cognitive impairment that is documented in medical chart.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04106011